Characterization of a re‐engineered, mesothelin‐targeted<i>Pseudomonas</i>exotoxin fusion protein for lung cancer therapyFrieder Bauss, Gerhard Niederfellner, Frank Herting et al.|Molecular Oncology|2016Cited by 56
Translating pharmacology models effectively to predict therapeutic benefitSherri Dudal, Lotte Winther, Caterina Bissantz et al.|Drug Discovery Today|2022Cited by 15